News Home » World » FDA to approve more ‘boosters’ before human trials complete

Around the World

FDA to approve more ‘boosters’ before human trials complete

Randy Mancini 3 Aug 28
HINES, ILLINOIS - APRIL 01: A nurse administers a second COVID-19 booster shot to a patient at Edward Hines Jr. VA Hospital on April 01, 2022 in Hines, Illinois. Earlier this week the CDC updated its recommendations to encourage a second COVID-19 booster shot for certain immunocompromised individuals and people over the age of 50 who received an initial booster dose at least 4 months ago. (Photo by Scott Olson/Getty Images)

HINES, ILLINOIS – APRIL 01: A nurse administers a second COVID-19 booster shot to a patient at Edward Hines Jr. VA Hospital on April 01, 2022 in Hines, Illinois. (Photo by Scott Olson/Getty Images)

The FDA is set to approve yet another ‘booster’ shot for COVID-19 despite human testing not being completed.

According to reports from Sunday, the agency will authorize the next round of boosters before studies show whether it’s safe or efficient for humans. FDA officials claimed that the rush is necessary to ‘protect’ the population from, what they expect to be, another COVID-19 surge in the fall.

The agency did not address the hundreds-of-thousands of injuries and deaths caused by COVID-19 vaccines. FDA Vaccine Chief Dr. Peter Marks spoke on the announcement.

“What we’re hoping to achieve with these boosters is to restore the level of protection toward that which we saw with the original vaccines in which we not only protected against hospitalization and death, but we also protected against symptomatic disease,” explained Marks.

There has been numerous cases of COVID-19 in ‘fully-vaccinated’ patients including in President Joe Biden and First Lady Jill Biden, former White House Spokesperson Jen Psaki and in a number of high-profile Democrats.

MORE NEWS: L.A. To Vote On Housing Homeless In Hotels